SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARTERIAL VASCULAR ENGINEERING -- Ignore unavailable to you. Want to Upgrade?


To: Jeff Gurian who wrote (315)12/10/1997 2:32:00 PM
From: Zeus549  Read Replies (1) | Respond to of 339
 
Hi Jeff, Good luck with AVEI. I'm out until I see a pretty severe pullback.(which or course may never happen) Currently I think there is too much already figured into the price. Now it could be they have some kind of surprise in the mergers and acquisitions which could send it flying higher--but who knows about that--not I. I'm sure they will be getting their FDA approval in pretty short order and should get some kind of pop from that. Overall I think the market is ripe for a good tumble again. Lot of money coming in at the end of the year that needs a home but they don't want it at the current levels IMO and will try to shake out the weak hands at least one more time before they start poring in the doe.



To: Jeff Gurian who wrote (315)12/14/1997 11:24:00 PM
From: Dan Woodbury  Read Replies (2) | Respond to of 339
 
Since AVEI's sales are predominately in Europe and Japan, what impact will the strong dollar have on revenues and profits? I agree that AVEI seems to have a tremendous upside but it also has a huge downside (at least in the short term) if profits are dissapointing. Don't forget that last year the stock fell from 25 to 10 in about 2 months time.

So what impact will the strong dollar have? I'd hate to own any shares of AVEI if the company announced that it missed earnings because of currency issues.